Dr Boreham s Crucible: Will Suda s rebirth under Paul Hopper be another mist opportunity? stockhead.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockhead.com.au Daily Mail and Mail on Sunday newspapers.
Head and Founder of DanCann Pharma Wins 2021 Business Worldwide Magazine CEO Award
News provided by
Share this article
Share this article
LONDON, May 18, 2021 /PRNewswire/ The CEO and founder of DanCann Pharma A/S, Jeppe Krog Rasmussen, has been named in this year s Business Worldwide Magazine CEO Awards. He was the outright winner in his category - Most innovative CEO in Europe s Pharmaceuticals Industry.
The awards seek to identify and honour the Most Respected C-level executives across the globe from a variety of different sectors. Unlike many other business awards that focus on the overall success of a company, here the spotlight is on the success of individuals who make the corporations tick– namely senior executives such as CEOs, Managing Directors, Directors and senior-level management. The intention is to give a worthy individual the recognition they deserve, whilst using their example to inspire other companies and business leaders to achieve similar success.
Head and Founder of DanCann Pharma Wins 2021 Business Worldwide Magazine CEO Award prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios
ACCESSWIRE
This Definitive Agreement is expected to generate an excess of $
47,5M CAD
), a leader in cannabinoid-derived drug discovery and development announced today the signing of a Definitive Agreement with DanCann Pharma A/S (SS: DANCAN) for the exclusive distribution of Reduvo™ Adversa®, QIXLEEF™ and ENJOUCA™ in Denmark, Norway, Sweden, Finland, and Germany.
Subject to registration with the European Medicines Agency (EMA), DanCann Pharma will handle the exclusive sales and distribution in the Nordics and Germany for Reduvo™ Adversa® and QIXLEEF™, a botanical cannabinoid-derived medicine, as well as Tetra s medicinal cannabis product ENJOUCA™.
April 5, 2021 at 10:32 am Published by NCV Newswire
Subversive Acquisition LP Announces InterCure’s Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings
InterCure Signs Letter of Intent with Cann Pharmaceutical Ltd.
Acquisition Strengthens InterCure’s Position as the Largest Cannabis Company Outside of North America
TORONTO, April 05, 2021 (GLOBE NEWSWIRE) SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that InterCure Ltd. (dba Canndoc) (TASE: INCR) (“InterCure”), Israel’s leading cannabis company and SVX’s intended target for its “Qualifying Transaction” (the “Transaction”), has signed a Letter of Intent (“LOI”) with Cann Pharmaceutical Ltd. (“Cann”) to acquire Better Holdings (“Better”), a pioneering medical cannabis operator in Israel and Australia. Under the terms of the agreement, InterCure will acquire 100% of Cann’s shares, whic